Randomized, double-blind, placebo-controlled trial of sulindac in individuals at risk for melanoma: evaluation of potential chemopreventive activity. [electronic resource]
Producer: 20130306Description: 5848-56 p. digitalISSN:- 1097-0142
- Adult
- Anti-Inflammatory Agents, Non-Steroidal -- therapeutic use
- Caspase 3 -- metabolism
- Double-Blind Method
- Female
- Humans
- Male
- Medication Adherence
- Melanoma -- prevention & control
- Middle Aged
- Nevus -- drug therapy
- Skin Neoplasms -- prevention & control
- Sulindac -- pharmacokinetics
- Vascular Endothelial Growth Factor A -- analysis
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.